State of Wisconsin Investment Board
RUBY

State of Wisconsin Investment Board’s Rubius Therapeutics, Inc RUBY Stock Holding History

State of Wisconsin Investment Board’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-134,400
Closed -$741K – 2916
2022
Q1 		$741K Buy
134,400
+55,100
+69% +$350K ﹤0.01% 1706
2021
Q4 		$768K Buy
79,300
+15,500
+24% +$215K ﹤0.01% 1533
2021
Q3 		$1.14M Buy
63,800
+3,100
+5% +$67.4K ﹤0.01% 1415
2021
Q2 		$1.48M Hold
60,700
– – ﹤0.01% 1351
2021
Q1 		$1.61M Buy
60,700
+12,800
+27% +$187K ﹤0.01% 1271
2020
Q4 		$364K Sell
47,900
-6,000
-11% -$35.6K ﹤0.01% 1634
2020
Q3 		$270K Sell
53,900
-11,200
-17% -$59.3K ﹤0.01% 1863
2020
Q2 		$389K Buy
65,100
+5,700
+10% +$33.6K ﹤0.01% 1493
2020
Q1 		$264K Buy
59,400
+7,000
+13% +$52K ﹤0.01% 1530
2019
Q4 		$498K Hold
52,400
– – ﹤0.01% 1439
2019
Q3 		$411K Buy
52,400
+2,800
+6% +$32.6K ﹤0.01% 1387
2019
Q2 		$780K Buy
49,600
+33,300
+204% +$537K ﹤0.01% 1201
2019
Q1 		$295K Buy
16,300
+3,700
+29% +$56.8K ﹤0.01% 1422
2018
Q4 		$203K Hold
12,600
– – ﹤0.01% 1456
2018
Q3 		$302K Buy
+12,600
New +$288K ﹤0.01% 1466

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $293M AUM 36.12% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State of Wisconsin Investment Board's RUBY Position: Q2 2022 in Review

State of Wisconsin Investment Board sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 134,400 shares — an estimated $741K sold.

State of Wisconsin Investment Board first reported a position in RUBY in Q3 2018 and held it in 15 quarters. The position peaked at $1.61M in Q1 2021. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • State of Wisconsin Investment Board reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 134,400 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $741K.
  • State of Wisconsin Investment Board first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 15 quarters.
  • State of Wisconsin Investment Board's Rubius Therapeutics, Inc position peaked at $1.61M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2022, filed 15 Aug 2022.